SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-052014
Filing Date
2018-08-14
Accepted
2018-08-14 17:20:42
Documents
5
Period of Report
2018-08-09
Items
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18802_18k.htm 8-K 42300
2 EX-10.1 a18-18802_1ex10d1.htm EX-10.1 836041
3 EX-10.2 a18-18802_1ex10d2.htm EX-10.2 884079
4 EX-99.1 a18-18802_1ex99d1.htm EX-99.1 23995
5 GRAPHIC g188021mmi001.jpg GRAPHIC 6437
  Complete submission text file 0001104659-18-052014.txt   1797025
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37691 | Film No.: 181018923
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1